Aurora Cannabis Inc. (ACB)
NASDAQ: ACB · Real-Time Price · USD
5.89
+0.03 (0.51%)
At close: Feb 21, 2025, 4:00 PM
5.98
+0.09 (1.53%)
After-hours: Feb 21, 2025, 7:53 PM EST
Aurora Cannabis Revenue
Aurora Cannabis had revenue of 88.20M CAD in the quarter ending December 31, 2024, with 37.01% growth. This brings the company's revenue in the last twelve months to 320.81M, up 20.72% year-over-year. In the fiscal year ending March 31, 2024, Aurora Cannabis had annual revenue of 270.28M with 20.77% growth.
Revenue (ttm)
320.81M CAD
Revenue Growth
+20.72%
P/S Ratio
1.45
Revenue / Employee
298,984 CAD
Employees
1,073
Market Cap
322.22M USD
Revenue Chart
* This company reports financials in CAD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2024 | 270.28M | 46.48M | 20.77% |
Mar 31, 2023 | 223.80M | 2.47M | 1.11% |
Jun 30, 2022 | 221.34M | -23.91M | -9.75% |
Jun 30, 2021 | 245.25M | -23.45M | -8.73% |
Jun 30, 2020 | 268.70M | 23.17M | 9.44% |
Jun 30, 2019 | Pro | Pro | Pro |
Jun 30, 2018 | Pro | Pro | Pro |
Jun 30, 2017 | Pro | Pro | Pro |
Jun 30, 2016 | Pro | Pro | Pro |
Jun 30, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 400.28B |
Johnson & Johnson | 88.82B |
Merck & Co. | 64.17B |
AbbVie | 56.33B |
AstraZeneca | 54.07B |
Novartis AG | 51.72B |
Eli Lilly and Company | 45.04B |
Thermo Fisher Scientific | 42.88B |
ACB News
- 5 hours ago - Aurora Cannabis: This Phoenix Has Risen From The Ashes (Strong Buy Initiation) - Seeking Alpha
- 1 day ago - Aurora Cannabis Expands Medical Cannabis Pastille Offerings in Australia - PRNewsWire
- 7 days ago - Breaking Down Barriers: Aurora Cannabis Eases Patient Access to High Quality Medical Cannabis Products in Australia - PRNewsWire
- 12 days ago - Aurora Cannabis: Strong Buy On Blowout Results And Constructive Outlook - Seeking Alpha
- 15 days ago - 3 Marijuana Stocks To Watch As Trading Momentum May Soon Rise - MarijuanaStocks
- 15 days ago - Aurora Cannabis Announces Supply Agreement with SNDL - PRNewsWire
- 16 days ago - Aurora Cannabis: Remarkable Recovery - Seeking Alpha
- 16 days ago - Aurora Cannabis Inc. (ACB) Q3 2025 Earnings Call Transcript - Seeking Alpha